Private Equity

Updated:

Life Science Vision Capital

Life Science Vision Capital is a private equity firm based in London, UK. It focuses on a Venture Capital investment approach. The firm is headquartered in the...

Life Science Vision Capital logo

Life Science Vision Capital

Life Science Vision Capital is a private equity firm based in London, UK. It focuses on a Venture Capital investment approach. The firm is headquartered in the UK.

General information

Firm type

Private Equity

Year founded

2019

Location

Region

Europe

Country

United Kingdom

City

London

Corporate office

London, United Kingdom

Sector focus

Life Sciences

Frequently asked questions

Who runs investment decisions at Life Science Vision Capital?

No investment decision-makers are publicly identified. The firm's website and LinkedIn presence offer no named principals, investment committee members, or scientific advisory board rosters, which is atypical for an early-stage life sciences manager.

How does Life Science Vision Capital source proprietary deal flow?

Sourcing channels are not disclosed. In the absence of a named team, university partnerships, or published portfolio companies, there is no visible evidence of an active proprietary origination network as of mid-2026.

What investment stages does Life Science Vision Capital typically target?

The firm's stated strategy covers early-stage investments, including seed and start-up rounds, within the life sciences sector. No specific check-size ranges, reserve ratios, or follow-on policies have been published.

Is Life Science Vision Capital currently investing from a committed fund?

No fund vehicle, vintage year, or target size has been publicly announced. The firm's 'Coming Soon' website as of May 2026 indicates that any formal fundraise or investment vehicle may not yet be live.

Does Life Science Vision Capital publicly disclose its portfolio?

No portfolio companies, exited investments, or co-investment partners are listed on the firm's website or identifiable through primary-source disclosures. The track record is opaque from the outside.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More London Private Equity profiles